Terumo Blood and Cell Technologies and Charles River Laboratories have announced the successful integration of Terumo BCT’s Finia automated fill-finish system into a complex cell and gene therapy (CGT) workflow. The collaboration highlights the platform’s adaptability for handling varying product volumes and maintaining critical cell quality parameters.   Fill-finish is a particularly challenging step in CGT manufacturing due to the products’ personalized nature and short shelf life. Terumo BC...